Premium
Retrograde endoscopic laser therapy for transitional cell carcinoma of the upper urinary tract
Author(s) -
MUGIYA SOICHI,
MARUYAMA SATOSHI,
NAGATA MASAO,
HADANO SHINSUKE,
NAGAE HIROSHI
Publication year - 2003
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2003.00646.x
Subject(s) - medicine , ureteroscopy , surgery , upper urinary tract , transitional cell carcinoma , renal pelvis , endoscopy , ureter , urinary system , blood transfusion , endoscopic treatment , urology , cancer , bladder cancer
Aim: The aim of the present study was to investigate the safety and efficacy of endoscopic laser therapy for transitional cell carcinoma (TCC) of the upper urinary tract. Methods: Tumors of the renal pelvis and ureteropelvic junction were detected by ureteroscopy. The tumors were subjected to biopsy, and after TCC was diagnosed, endoscopic laser therapy (Neodymium‐YAG and Holmium‐YAG) was conducted using a 6.9 Fr. flexible ureterorenoscope. Results: From January 1997 to April 2002, six patients underwent ureteroscopic treatment. Tumor grade was 1 in four patients and 2 in two patients. Average tumor size was 1.45 cm. Endoscopic treatment was chosen for two patients because of the high medical risk associated with open surgery. Another patient underwent diagnostic ureteroscopy, followed immediately by endoscopic treatment. A further three patients elected to undergo ureteroscopic treatment. One patient with large (3 cm), multifocal and incompletely treated tumors died of metastatic disease 22 months after the initial operation. One patient requested nephroureterectomy one month after endoscopic treatment, and pathological examination of the resected specimen revealed no tumor. The other four patients have been followed up for a mean period of 14 months after initial treatment. Recurrence occurred in one patient, and was successfully treated by repeat endoscopic resection. None of the patients required blood transfusion or emergency open surgery. Conclusion: Ureteroscopic treatment of small, localized, low‐grade TCC of the upper urinary tract is now a safe and feasible alternative to nephroureterectomy in selected patients.